Fatigue strength of bilayer yttria-stabilized zirconia after low-temperature degradation.

This study examined the impact of interfacial interactions on bilayer yttria-stabilized zirconia (YSZ) used in dental restorations. In-house bilayer structures of 3YSZ and 5YSZ composition underwent hydrothermal degradation to compare the properties of control and low-temperature degradation (LTD) treated groups. Biaxial flexural strength via piston-on-three-balls, staircase fatigue strength over 10 cycles at 15 Hz, phase characterization and quantification through XRD and Rietveld refinement, and fractography were conducted.

A comparative study of mechanical properties of yttria stabilized zirconia monolithic and bilayer configuration for dental application.

Zirconia multilayer presents promising prospects, but there is scarce information about its microstructural and mechanical characterization. Therefore, this study sought to produce them in-house and to perform their characterization by comprising four groups of specimens to assess the biaxial flexural strength, microhardness, fracture toughness, phase characterization and quantification, fractography, and microstructural features. Weibull analysis was performed to determine the Weibull modulus and characteristic strength.

An engineering perspective of ceramics applied in dental reconstructions.

The demands for dental materials continue to grow, driven by the desire to reach a better performance than currently achieved by the available materials. In the dental restorative ceramic field, the structures evolved from the metal-ceramic systems to highly translucent multilayered zirconia, aiming not only for tailored mechanical properties but also for the aesthetics to mimic natural teeth. Ceramics are widely used in prosthetic dentistry due to their attractive clinical properties, including high strength, biocompatibility, chemical stability, and a good combination of optical properties.

Current advances in drug delivery of nanoparticles for respiratory disease treatment.

Cases of respiratory diseases have been increasing around the world, affecting the health and quality of life of millions of people every year. Chronic respiratory diseases (CRDs) and acute respiratory infections (ARIs) are responsible for many hospital admissions and deaths, requiring sophisticated treatments that facilitate the delivery of therapeutics to specific target sites with controlled release. In this context, different nanoparticles (NPs) have been explored to match this demand, such as lipid, liposome, protein, carbon-based, polymeric, metallic, oxide, and magnetic NPs.